Top compounds associated with response to MT-ND4L


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.01
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.1 0.02
mRNA etoposide CTRPv2 pan-cancer AAC -0.08 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.02
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.02
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.02
mRNA clofarabine CTRPv2 pan-cancer AAC -0.075 0.02
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.095 0.02
mRNA XL765 CTRPv2 pan-cancer AAC -0.097 0.02
Download CSV